Research Citations Semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1 RA), has emerged as a promising therapy for type 2 diabetes mellitus (T2DM) due to its potent glucose-lowering effects and cardiovascular benefits
, fluoxetine (78) sertraline (79), promote remission in acute experimental autoimmune encephalomyelitis) BPC 157 affects with region specific influence the brain serotonin synthesis (-[14C]methyl-l-tryptophan autoradiographic measurements) (80), reduces the duration of immobility to a greater extent than imipramine (81)
Nutrition Tips for Success with GLP-1 Medications Schedule meals and snacks : Eating every four to five hours helps prevent overeating or getting too hungry
Among n=186,975, n=174,277, n=116,234, and n=219,110 lower extremity joint replacement, hysterectomy, appendectomy and cholecystectomy surgeries, respectively, the preoperative use of GLP-1 agonists varied between 0.6% and 2.0%
Example combined protocol: Morning: CJC-1295 (100mcg) + Ipamorelin (100mcg) Evening: GHK-CU (1-2mg) Separating administration times prevents potential interactions at the injection site and allows each peptide to work through its distinct pathways without interference
As of May 2025, Health Canada has approved Zepbound, but it is not yet available in Canadian pharmacies